Biomarkers and epidemiology
21 – 30 of 138
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
(
- Contribution to journal › Article
-
Mark
Reply to Paulius Bosas, Gintaras Zaleskis, and Dainius Characiejus's Letter to the Editor re : Sylvia H.J. Jochems, Josef Fritz, Christel Häggström, Bengt Järvholm, Pär Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033. Therapeutic Monitoring in Prostate Cancer Should Involve a Cotinine Test in Current Smokers: Smoking Cessation Remains a Cornerstone in Preventive Health Care Overall and for Men with Prostate Cancer
(
- Contribution to journal › Letter
-
Mark
Analysing high-throughput sequencing data in Python with HTSeq 2.0
(
- Contribution to journal › Article
-
Mark
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
(
- Contribution to journal › Article
-
Mark
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
(
- Contribution to journal › Article
-
Mark
Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
(
- Contribution to journal › Article
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer
(
- Contribution to journal › Article
-
Mark
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up
(
- Contribution to journal › Article
-
Mark
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
(
- Contribution to journal › Article